Mechanisms of calcineurin inhibitor-induced neurotoxicity

Transplantation Reviews

Volumn 20, Issue 1, 2006, Pages 49-60

  Tan, Timothy C ^a,b   Robinson, Phillip J ^a,c  

^a University of Sydney   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BINDING PROTEIN; CALCINEURIN; CALCIUM ION; CYCLIC AMP; CYCLOSPORIN A; GLUTAMATE DECARBOXYLASE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; SYNAPSIN; TACROLIMUS; TRANSCRIPTION FACTOR; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN NERVE CELL; CELL FUNCTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DRUG EXPOSURE; DRUG MECHANISM; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; EXOCYTOSIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LEARNING; MEMORY; NEPHROTOXICITY; NERVE CELL EXCITABILITY; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; ORGAN TRANSPLANTATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SYNAPTIC TRANSMISSION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 33645885599     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2006.02.005     Document Type: Review

References (134)

1. Mihatsch M.J., Kyo M., Morozumi K., Yamaguchi Y., Nickeleit V., and Ryffel B. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 49 (1998) 356-363
2. Marks A.R. Cellular functions of immunophilins. Physiol Rev 76 (1996) 631-649
3. Wijdicks E.F. Neurotoxicity of immunosuppressive drugs. Liver Transpl 7 (2001) 937-942
4. Bechstein W.O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13 (2000) 313-326
5. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80 (1996) S40-S45
6. Yakel J.L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 18 (1997) 124-134
7. Guerini D. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun 235 (1997) 271-275
8. Klee C.B., Draetta G.F., and Hubbard M.J. Calcineurin. Adv Enzymol 61 (1988) 149-200
9. +- and protein modulator-activated cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 72 (1976) 926-932
10. Klee C.B., Crouch T.H., and Krinks M.H. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 76 (1979) 6270-6273
11. Kincaid R.L., Balaban C.D., and Billingsley M.L. Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. Proc Natl Acad Sci U S A 84 (1987) 1118-1122
12. Maramattom B.V., and Wijdicks E.F. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology 63 (2004) 1958-1959
13. Gijtenbeek J.M., van den Bent M.J., and Vecht C.J. Cyclosporine neurotoxicity: a review. J Neurol 246 (1999) 339-346
14. Wijdicks E.F., Wiesner R.H., Dahlke L.J., and Krom R.A. FK506-induced neurotoxicity in liver transplantation. Ann Neurol 35 (1994) 498-501
15. +- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett 137 (1982) 80-84
16. Mansuy I.M. Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun 311 (2003) 1195-1208
17. Kahan B.D. Cyclosporine. N Engl J Med 321 (1989) 1725-1738
18. Zheng W. Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol 39 (2001) 711-719
19. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu Rev Neurosci 22 (1999) 11-28
20. van Bree J.B., de Boer A.G., Danhof M., Ginsel L.A., and Breimer D.D. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J Pharmacol Exp Ther 247 (1988) 1233-1239
21. De Groen P.C. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 63 (1988) 1012-1021
22. Halloran P.F., Kung L., and Noujaim J. Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc 30 (1998) 2167-2170
23. Jesmin S., Togashi H., Sakuma I., Mowa C.N., Ueno K., Yamaguchi T., et al. Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder. Endocrinology 145 (2004) 4330-4343
24. Lossinsky A.S., and Shivers R.R. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Histol Histopathol 19 (2004) 535-564
25. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
26. Baldwin A.C., and Kielian T. Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151 (2004) 24-32
27. Boveri M., Kinsner A., Berezowski V., Lenfant A.M., Draing C., Cecchelli R., et al. Price, highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 137 (2005) 1193-1209
28. Stolp H.B., Dziegielewska K.M., Ek C.J., Potter A.M., and Saunders N.R. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 22 (2005) 2805-2816
29. Yamauchi A., Shuto H., Dohgu S., Nakano Y., Egawa T., and Kataoka Y. Cyclosporin A aggravates electroshock-induced convulsions in mice with a transient middle cerebral artery occlusion. Cell Mol Neurobiol 25 (2005) 923-928
30. Sander M., Lyson T., Thomas G.D., and Victor R.G. Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens 9 (1996) 121S-138S
31. Dawson T.M., Steiner J.P., Lyons W.E., Fotuhi M., Blue M., and Snyder S.H. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. Neurosci 62 (1994) 569-580
32. Kung L., and Halloran P.F. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 70 (2000) 327-335
33. Soltenburg-Didinger G., and Boegner F. Glia toxicity in dissociation cell cultures induced by cyclosporine. Neurotoxicol 13 (1992) 179-184
34. McDonald J.W., Goldberg M.P., Gwag B.J., Chi S.I., and Choi D.W. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol 40 (1996) 750-758
35. McDiarmid S.V., Busuttil R.W., Ascher N.L., Burdick J., D'Alessandro A.M., Esquivel C., et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation 59 (1995) 530-536
36. Guarino M., Stracciari A., Pazzaglia P., Sterzi R., Santilli I., Donato F., et al. Neurological complications of liver transplantation. J Neurol 243 (1996) 137-142
37. Palmer B.F., and Toto R.D. Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 18 (1991) 116-121
38. Freise C.E., Rowley H., Lake J., Hebert M., Ascher N.L., and Roberts J.P. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc 23 (1991) 3173-3174
39. Burns M.E., and Augustine G.J. Synaptic structure and function: dynamic organization yields architectural precision. Cell 83 (1996) 187-194
40. Cousin M.A., and Robinson P.J. The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci 24 (2001) 659-665
41. Kaminska B., Gaweda-Walerych K., and Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 8 (2004) 45-58
42. Trifaró J.-M., and Vitale M.L. Cytoskeleton dynamics during neurotransmitter release. Trends Neurosci 16 (1993) 466-472
43. Hirokawa N., Sobue K., Kanda K., Harada A., and Yorifuji H. The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin 1. J Cell Biol 108 (1989) 111-126
44. Nichols R.A., Suplick G.R., and Brown J.M. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J Biol Chem 269 (1994) 23817-23823
45. Sihra T.S., Nairn A.C., Kloppenburg P., Lin Z., and Pouzat C. A role for calcineurin (protein phosphatase-2B) in the regulation of glutamate release. Biochem Biophys Res Commun 212 (1995) 609-616
46. Baldwin M.L., Rostas J.A., and Sim A.T. Two modes of exocytosis from synaptosomes are differentially regulated by protein phosphatase types 2A and 2B. J Neurochem 85 (2003) 1190-1199
47. Victor R.G., Thomas G.D., Marban E., and O'Rourke B. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc Natl Acad Sci U S A 92 (1995) 6269-6273
48. Benfenati F., Bahler M., Jahn R., and Greengard P. Interactions of synapsin I with small synaptic vesicles: distinct sites in synapsin I bind to vesicle phospholipids and vesicle proteins. J Cell Biol 108 (1989) 1863-1872
49. King M.M., Huang C.Y., Chock P.B., Nairn A.C., Hemmings H.C., Chan K.F., et al. Mammalian brain phosphoproteins as substrates for calcineurin. J Biol Chem 259 (1984) 8080-8083
50. +-dependent glutamate release in isolated nerve terminals. J Neurosci 21 (2001) 7944-7953
51. Brent P.J., Haynes H., Jarvie P.E., Mudge L., Sim A.T.R., and Dunkley P.R. Phosphorylation of synapsin I and dynamin in rat forebrain synaptosomes: modulation by sigma (σ) ligands. Neurosci Lett 191 (1995) 71-74
52. Greengard P., Valtorta F., Czernik A.J., and Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259 (1993) 780-785
53. Valtorta F., Greengard P., Fesce R., Chieregatti E., and Benfenati F. Effects of the neuronal phosphoprotein synapsin I on actin polymerization. I. Evidence for a phosphorylation-dependent nucleating effect. J Biol Chem 267 (1992) 11281-11288
54. Ceccaldi P.-E., Grohovaz F., Benfenati F., Chieregatti E., Greengard P., and Valtorta F. Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: an analysis by videomicroscopy. J Cell Biol 128 (1995) 905-912
55. Yamagata Y., Jovanovic J.N., Czernik A.J., Greengard P., and Obata K. Bidirectional changes in synapsin I phosphorylation at MAP kinase-dependent sites by acute neuronal excitation in vivo. J Neurochem 80 (2002) 835-842
56. Groth R.D., Dunbar R.L., and Mermelstein P.G. Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311 (2003) 1159-1171
57. Chi P., Greengard P., and Ryan T.A. Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron 38 (2003) 69-78
58. Zhang W., Li J.L., Hosaka M., Janz R., Shelton J.M., Albright G.M., et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci U S A 97 (2000) 9765-9770
59. Lane-Guermonprez L., Morot-Gaudry-Talarmain Y., Meunier F.M., O'Regan S., Onofri F., Le Caer J.P., et al. Synapsin associates with cyclophilin B in an ATP- and cyclosporin A-dependent manner. J Neurochem 93 (2005) 1401-1411
60. van der Bliek A.M., Redelmeier T.E., Damke H., Tisdale E.J., Meyerowitz E.M., and Schmid S.L. Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol 122 (1993) 553-563
61. Takei K., McPherson P.S., Schmid S.L., and De Camilli P. Tubular membrane invaginations coated by dynamin rings are induced by GTP-γS in nerve terminals. Nature 374 (1995) 186-190
62. Shupliakov O., Low P., Grabs D., Gad H., Chen H., David C., et al. Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science 276 (1997) 259-263
63. Cremona O., Di Paolo G., Wenk M.R., Luthi A., Kim W.T., Takei K., et al. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99 (1999) 179-188
64. Carbone R., Fre S., Iannolo G., Belleudi F., Mancini P., Pelicci P.G., et al. Eps15 and eps15R are essential components of the endocytic pathway. Cancer Res 57 (1997) 5498-5504
65. Benmerah A., Lamaze C., Begue B., Schmid S.L., Dautry-Varsat A., and Cerf-Bensussan N. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J Cell Biol 140 (1998) 1055-1062
66. Chen H., Fre S., Slepnev V.I., Capua M.R., Takei K., Butler M.H., et al. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature 394 (1998) 793-797
67. Morgan J.R., Zhao X., Womack M., Prasad K., Augustine G.J., and Lafer E.M. A role for the clathrin assembly domain of AP180 in synaptic vesicle endocytosis. J Neurosci 19 (1999) 10201-10212
68. Haffner C., Paolo G.D., Rosenthal J.A., and De Camilli P. Direct interaction of the 170 kDa isoform of synaptojanin 1 with clathrin and with the clathrin adaptor AP-2. Curr Biol 10 (2000) 471-474
69. Cousin M.A., Tan T.C., and Robinson P.J. Protein phosphorylation is required for endocytosis in nerve terminals. Potential role for the dephosphins dynamin I and synaptojanin, but not AP180 or amphiphysin. J Neurochem 76 (2001) 105-116
70. Slepnev V.I., Ochoa G.C., Butler M.H., Grabs D., and DeCamilli P. Role of phosphorylation in regulation of the assembly of endocytic coat complexes. Science 281 (1998) 821-824
71. Chen H., Slepnev V.I., Di Fiore P.P., and De Camilli P. The interaction of epsin and eps15 with the clathrin adaptor AP-2 is inhibited by mitotic phosphorylation and enhanced by stimulation-dependent dephosphorylation in nerve terminals. J Biol Chem 274 (1999) 3257-3260
72. Kariya K., Koyama S., Nakashima S., Oshiro T., Morinaka K., and Kikuchi A. Regulation of complex formation of POB1/epsin/adaptor protein complex 2 by mitotic phosphorylation. J Biol Chem 275 (2000) 18399-18406
73. 2+-sensitive phospholipid-binding protein with very high affinity for protein kinase C. J Biol Chem 269 (1994) 21043-21050
74. Powell K.A., Valova V.A., Malladi C.S., Jensen O.N., Larsen M.R., and Robinson P.J. Phosphorylation of dynamin I on Ser-795 by protein kinase C blocks its association with phospholipids. J Biol Chem 275 (2000) 11610-11617
75. Lai M.M., Hong J.J., Ruggiero A.M., Burnett P.E., Slepnev V.I., De Camilli P., et al. The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis. J Biol Chem 274 (1999) 25963-25966
76. Liu J.P., Sim A.T.R., and Robinson P.J. Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science 265 (1994) 970-973
77. Marks B., and McMahon H.T. Calcium triggers calcineurin-dependent synaptic vesicle recycling in mammalian nerve terminals. Curr Biol 8 (1998) 740-749
78. Lai M.M., Luo H.R., Burnett P.E., Hong J.J., and Snyder S.H. The calcineurin binding protein Cain is a negative regulator of synaptic vesicle endocytosis. J Biol Chem 275 (2000) 34017-34020
79. Bon C.L., and Garthwaite J. On the role of nitric oxide in hippocampal long-term potentiation. J Neurosci 23 (2003) 1941-1948
80. Knowles R.G., Palacios M., Palmer R.M., and Moncada S. Formation of nitric oxide from l-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A 86 (1989) 5159-5162
81. Schuman E.M., and Madison D.V. Nitric oxide and synaptic function. Annu Rev Neurosci 17 (1994) 153-183
82. Baranano D.E., Ferris C.D., and Snyder S.H. Atypical neural messengers. Trends Neurosci 24 (2001) 99-106
83. Kiss J.P., and Vizi E.S. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24 (2001) 211-215
84. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., and Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A 90 (1993) 9808-9812
85. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
86. Bao J., Cheung W.Y., and Wu J.Y. Brain l-glutamate decarboxylase. Inhibition by phosphorylation and activation by dephosphorylation. J Biol Chem 270 (1995) 6464-6467
87. Wang J., Liu S., Haditsch U., Tu W., Cochrane K., Ahmadian G., et al. Interaction of calcineurin and type-A GABA receptor gamma 2 subunits produces long-term depression at CA1 inhibitory synapses. J Neurosci 23 (2003) 826-836
88. Chad J.E., and Eckert R. An enzymatic mechanism for calcium current inactivation in dialysed Helix neurones. J Physiol 378 (1986) 31-51
89. + currents in rat thalamocortical relay neurons by activity and phosphorylation. Eur J Neurosci 15 (2002) 1603-1614
90. Wu Z.Z., Chen S.R., and Pan H.L. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J Biol Chem 280 (2005) 18142-18151
91. +) currents via a PLCbeta/IP3/calcineurin signaling cascade. J Neurophysiol 87 (2002) 2490-2504
92. + currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci 20 (2000) 8987-8995
93. Lai Y., Peterson B.Z., and Catterall W.A. Selective dephosphorylation of the subunits of skeletal muscle calcium channels by purified phosphoprotein phosphatases. J Neurochem 61 (1993) 1333-1339
94. +) current to protein kinase A: role of calmodulin. Am J Physiol Heart Circ Physiol 286 (2004) H186-H194
95. +-activated phosphatase in mammalian brain. Trends Neurosci 12 (1989) 117-122
96. + entry. Eur J Neurosci 12 (2000) 2881-2891
97. Zhu Y., and Yakel J.L. Calcineurin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons. J Neurophysiol 78 (1997) 1161-1165
98. +) channel activity in hippocampal neurons: increased effect with age in culture. Neurosci 110 (2002) 213-225
99. + channels. Neuron 12 (1994) 1301-1318
100. Onuma H., Lu Y.F., Tomizawa K., Moriwaki A., Tokuda M., Hatase O., et al. A calcineurin inhibitor, FK506, blocks voltage-gated calcium channel-dependent LTP in the hippocampus. Neurosci Res 30 (1998) 313-319
101. Chang K.T., and Berg D.K. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 32 (2001) 855-865
102. Li S.T., Kato K., Tomizawa K., Matsushita M., Moriwaki A., Matsui H., et al. Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depression. J Neurosci 22 (2002) 5034-5041
103. Alagarsamy S., Saugstad J., Warren L., Mansuy I.M., Gereau R.W., and Conn P.J. NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology 49 Suppl 1 (2005) 135-145
104. Xia Z., and Storm D.R. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6 (2005) 267-276
105. Malenka R.C., and Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci 16 (1993) 521-527
106. +)-dependent phosphatase. Nature 369 (1994) 235-239
107. Tong G., and Jahr C.E. Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13 (1994) 1195-1203
108. Raman I.M., Tong G., and Jahr C.E. Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16 (1996) 415-421
109. Rycroft B.K., and Gibb A.J. Inhibitory interactions of calcineurin (phosphatase 2B) and calmodulin on rat hippocampal NMDA receptors. Neuropharmacology 47 (2004) 505-514
110. Krupp J.J., Vissel B., Thomas C.G., Heinemann S.F., and Westbrook G.L. Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors. Neuropharmacology 42 (2002) 593-602
111. Mallon A.P., Auberson Y.P., and Stone T.W. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-d:-aspartate receptors in hippocampal slices. Exp Brain Res 162 (2005) 374-383
112. Tong G., Shepherd D., and Jahr C.E. Synaptic desensitization of NMDA receptors by calcineurin. Science 267 (1995) 1510-1512
113. Zhou Q., Homma K.J., and Poo M.M. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 44 (2004) 749-757
114. +)/calmodulin-dependent protein kinase. J Neurosci 20 (2000) 2766-2773
115. Snyder G.L., Galdi S., Fienberg A.A., Allen P., Nairn A.C., and Greengard P. Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists. Neuropharmacology 45 (2003) 703-713
116. Colledge M., Dean R.A., Scott G.K., Langeberg L.K., Huganir R.L., and Scott J.D. Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27 (2000) 107-119
117. Lin J.W., Ju W., Foster K., Lee S.H., Ahmadian G., Wyszynski M., et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat Neurosci 3 (2000) 1282-1290
118. Morishita W., Marie H., and Malenka R.C. Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses. Nat Neurosci 8 (2005) 1043-1050
119. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., Von Zastrow M., et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci 3 (2000) 1291-1300
120. Chambard J.M., and Ashmore J.F. Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway. Pflugers Arch 450 (2005) 34-44
121. Misonou H., Mohapatra D.P., Park E.W., Leung V., Zhen D., Misonou K., et al. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 7 (2004) 711-718
122. + channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J Biol Chem 279 (2004) 18550-18558
123. Huang R.Q., and Dillon G.H. Maintenance of recombinant type A gamma-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin. J Pharmacol Exp Ther 286 (1998) 243-255
124. Chen Q.X., and Wong R.K. Suppression of GABAA receptor responses by NMDA application in hippocampal neurones acutely isolated from the adult guinea-pig. J Physiol 482 Pt 2 (1995) 353-362
125. Stelzer A., and Shi H. Impairment of GABAA receptor function by N-methyl-d-aspartate-mediated calcium influx in isolated CA1 pyramidal cells. Neurosci 62 (1994) 813-828
126. Sanchez R.M., Dai W., Levada R.E., Lippman J.J., and Jensen F.E. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain. J Neurosci 25 (2005) 3442-3451
127. Martina M., Mozrzymas J.W., Boddeke H.W., and Cherubini E. The calcineurin inhibitor cyclosporin A-cyclophilin A complex reduces desensitization of GABAA-mediated responses in acutely dissociated rat hippocampal neurons. Neurosci Lett 215 (1996) 95-98
128. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J Biol Chem 276 (2001) 2313-2316
129. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5 (2005) 472-484
130. Carlezon Jr. W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends Neurosci 28 (2005) 436-445
131. Graef I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401 (1999) 703-708
132. Groth R.D., and Mermelstein P.G. Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 23 (2003) 8125-8134
133. Graef I.A., Wang F., Charron F., Chen L., Neilson J., Tessier-Lavigne M., et al. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell 113 (2003) 657-670
134. +)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87 (1996) 1203-1214